These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9795064)

  • 1. Surface acidity of solid pharmaceutical excipients III. Excipients for solid dosage forms.
    Scheef CA; Oelkrug D; Schmidt PC
    Eur J Pharm Biopharm; 1998 Sep; 46(2):209-13. PubMed ID: 9795064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing.
    Govindarajan R; Zinchuk A; Hancock B; Shalaev E; Suryanarayanan R
    Pharm Res; 2006 Oct; 23(10):2454-68. PubMed ID: 16933092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of measurement conditions on the Hammett acidity function of solid pharmaceutical excipients.
    Zinchuk AV; Hancock BC; Shalaev EY; Reddy RD; Govindarajan R; Novak E
    Eur J Pharm Biopharm; 2005 Oct; 61(3):158-70. PubMed ID: 16005194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface engineered excipients: I. improved functional properties of fine grade microcrystalline cellulose.
    Chen L; Ding X; He Z; Huang Z; Kunnath KT; Zheng K; Davé RN
    Int J Pharm; 2018 Jan; 536(1):127-137. PubMed ID: 29191481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vapor Phase Alkyne Coating of Pharmaceutical Excipients: Discrimination Enhancement of Raman Chemical Imaging for Tablets.
    Yamashita M; Sasaki H; Moriyama K
    J Pharm Sci; 2015 Dec; 104(12):4093-4098. PubMed ID: 26343262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different types, applications and limits of enabling excipients of pharmaceutical dosage forms.
    Palcsó B; Zelkó R
    Drug Discov Today Technol; 2018 Jul; 27():21-39. PubMed ID: 30103860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural changes of polymer-coated microgranules and excipients on tableting investigated by microtomography using synchrotron X-ray radiation.
    Kajihara R; Noguchi S; Iwao Y; Suzuki Y; Terada Y; Uesugi K; Itai S
    Int J Pharm; 2015 Mar; 481(1-2):132-9. PubMed ID: 25660069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ¹³C solid-state NMR analysis of the most common pharmaceutical excipients used in solid drug formulations, Part I: Chemical shifts assignment.
    Pisklak DM; Zielińska-Pisklak MA; Szeleszczuk Ł; Wawer I
    J Pharm Biomed Anal; 2016 Apr; 122():81-9. PubMed ID: 26845204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.
    Wen L; Zheng X; Wang X; Lan H; Yin Z
    Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface acidity and solid-state compatibility of excipients with an acid-sensitive API: case study of atorvastatin calcium.
    Govindarajan R; Landis M; Hancock B; Gatlin LA; Suryanarayanan R; Shalaev EY
    AAPS PharmSciTech; 2015 Apr; 16(2):354-63. PubMed ID: 25319055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of excipient interactions on solid dosage form stability.
    Narang AS; Desai D; Badawy S
    Pharm Res; 2012 Oct; 29(10):2660-83. PubMed ID: 22707362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.